Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2025-12-25 @ 4:42 AM
NCT ID:
NCT00375518
Eligibility Criteria:
Inclusion Criteria:
* Adult patients ≥ 18 yr. scheduled for anatomic lung resection (segmentectomy, lingulectomy, possible or definite lobectomy, bilobectomy, pneumonectomy or extrapleural pneumonectomy) with or without chest wall resection or limited resection
* Patients with regular cardiac rhythm
* Patients able to take oral capsules
* Patients capable of providing written, informed consent
* Patients without known hepatic or kidney disease
Exclusion Criteria:
* Patients already taking any statin, gemfibrozil (Lopid), or ezetimibe (Zetia)
* Hypersensitivity to atorvastatin
* Chronic atrial fibrillation
* Patients already taking class Ic or III antiarrhythmic drugs
* Known pregnancy a urine pregnancy test will be given to women of childbearing age
* Known history of active hepatic disease or known hepatic insufficiency
* Known history of active kidney disease or insufficiency
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00375518
Study Brief:
Protocol Section:
NCT00375518